GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (NAS:CSBR) » Definitions » Cyclically Adjusted Book per Share

CSBR (Champions Oncology) Cyclically Adjusted Book per Share : $0.32 (As of Jul. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Champions Oncology Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Champions Oncology's adjusted book value per share for the three months ended in Jul. 2024 was $-0.024. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.32 for the trailing ten years ended in Jul. 2024.

During the past 12 months, Champions Oncology's average Cyclically Adjusted Book Growth Rate was -22.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Champions Oncology was 56.90% per year. The lowest was -14.60% per year. And the median was 12.70% per year.

As of today (2024-10-31), Champions Oncology's current stock price is $3.91. Champions Oncology's Cyclically Adjusted Book per Share for the quarter that ended in Jul. 2024 was $0.32. Champions Oncology's Cyclically Adjusted PB Ratio of today is 12.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Champions Oncology was 47.39. The lowest was 3.52. And the median was 17.50.


Champions Oncology Cyclically Adjusted Book per Share Historical Data

The historical data trend for Champions Oncology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology Cyclically Adjusted Book per Share Chart

Champions Oncology Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.30 0.43 0.47 0.32

Champions Oncology Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.37 0.34 0.32 0.32

Competitive Comparison of Champions Oncology's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Champions Oncology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Champions Oncology's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Champions Oncology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Champions Oncology's Cyclically Adjusted PB Ratio falls into.



Champions Oncology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Champions Oncology's adjusted Book Value per Share data for the three months ended in Jul. 2024 was:

Adj_Book= Book Value per Share /CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=-0.024/132.7078*132.7078
=-0.024

Current CPI (Jul. 2024) = 132.7078.

Champions Oncology Quarterly Data

Book Value per Share CPI Adj_Book
201410 -0.333 100.176 -0.441
201501 -0.743 98.604 -1.000
201504 0.926 99.824 1.231
201507 0.678 100.691 0.894
201510 0.472 100.346 0.624
201601 0.260 99.957 0.345
201604 0.027 100.947 0.035
201607 0.290 101.524 0.379
201610 0.292 101.988 0.380
201701 0.186 102.456 0.241
201704 0.036 103.167 0.046
201707 0.026 103.278 0.033
201710 0.034 104.070 0.043
201801 0.043 104.578 0.055
201804 0.000 105.708 0.000
201807 0.055 106.324 0.069
201810 0.174 106.695 0.216
201901 0.200 106.200 0.250
201904 0.193 107.818 0.238
201907 0.149 108.250 0.183
201910 0.182 108.577 0.222
202001 0.269 108.841 0.328
202004 0.401 108.173 0.492
202007 0.433 109.318 0.526
202010 0.516 109.861 0.623
202101 0.588 110.364 0.707
202104 0.554 112.673 0.653
202107 0.562 115.183 0.648
202110 0.598 116.696 0.680
202201 0.683 118.619 0.764
202204 0.673 121.978 0.732
202207 0.664 125.002 0.705
202210 0.676 125.734 0.713
202301 0.521 126.223 0.548
202304 0.342 127.992 0.355
202307 0.141 128.974 0.145
202310 0.007 129.810 0.007
202401 -0.151 130.124 -0.154
202404 -0.140 132.289 -0.140
202407 -0.024 132.708 -0.024

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Champions Oncology  (NAS:CSBR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Champions Oncology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.91/0.32
=12.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Champions Oncology was 47.39. The lowest was 3.52. And the median was 17.50.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Champions Oncology Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Champions Oncology's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Champions Oncology Business Description

Industry
Traded in Other Exchanges
Address
One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Executives
Daniel Newman Mendelson director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Ronnie Morris director, officer: President 855 N. WOLFE STREET, SUITE 619, BALTIMORE MD 21205
Philip P. Breitfeld director ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK NJ 07601
New Enterprise Associates 14, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Neeraj Agrawal 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Roger H Lee 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Michael Maurice Brown 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Battery Management Corp. 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
R David Tabors 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Jesse Feldman 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Joel Ackerman director, officer: Chief Executive Officer COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Patrick J Kerins 10 percent owner
Ryan D Drant 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Harry R Weller 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
Florence Anthony A. Jr. 10 percent owner 5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815